| Title | Date | PubMed ID |
|---|
| Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues. | 2015 May | 25744057 |
| Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites. | 2015 Feb 27 | 25555911 |
| Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration. | 2015 Feb | 25433194 |
| Urokinase-type plasminogen activator (uPA) stimulates triglyceride synthesis in Huh7 hepatoma cells via p38-dependent upregulation of DGAT2. | 2014 Nov | 25244504 |
| Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke. | 2014 Oct 22 | 25339736 |
| Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion. | 2014 Apr 15 | 24616477 |
| Urokinase-type plasminogen activator (uPA) decreases hepatic SR-BI expression and impairs HDL-mediated reverse cholesterol transport. | 2014 Mar | 24529115 |
| Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. | 2014 Jan | 24469103 |
| Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis. | 2013 Nov | 24125407 |
| Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer. | 2013 Sep | 23864708 |